Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARTL | MRNA | BMY | AMGN | GILD |
| Company | Artelo Biosciences Inc | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.3100 | 107.30 | 47.61 | 273.51 | 67.43 |
| High | 1.3418 | 107.30 | 47.61 | 273.51 | 67.43 |
| Low | 1.2800 | 107.30 | 47.61 | 273.51 | 67.43 |
| Last | 1.3418 | 107.30 | 47.61 | 273.51 | 67.43 |
| Change | +0.0318 | -1.55 | -1.25 | +0.50 | +0.35 |
| % Change | +2.43% | -1.42% | -2.56% | +0.18% | +0.52% |
| Volume | 5,400 | 25,682 | 210,427 | 1,155 | 8,471 |
| 20-Day Average Volume | 9,185 | 2,999,639 | 10,615,751 | 2,059,948 | 6,103,583 |
| Previous Close | 1.3100 | 108.85 | 48.86 | 273.01 | 67.08 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4576 | 105.06 | 50.08 | 270.91 | 68.79 |
| 20-Day Raw Stochastic | 26.24% | 54.53% | 0.00% | 46.01% | 19.20% |
| 20-Day Relative Strength | 41.42% | 54.42% | 36.21% | 48.72% | 35.24% |
| Weighted Alpha | -21.74 | -10.16 | -28.64 | +11.43 | -20.20 |
| Today's Opinion | 56% Sell | 100% Buy | 88% Sell | 40% Sell | 100% Sell |
| Previous Opinion | 56% Sell | 88% Buy | 88% Sell | 40% Sell | 100% Sell |
| Last Month's Opinion | 32% Buy | 72% Buy | 8% Sell | 24% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.04% since 04/17/24 | +5.20% since 04/18/24 | -1.43% since 04/18/24 | +4.10% since 04/18/24 | +1.92% since 04/18/24 |
| Low | 1.2500 on 04/18/24 | 99.30 on 04/22/24 | 47.61 on 04/25/24 | 260.68 on 04/19/24 | 66.16 on 04/19/24 |
| High | 1.3900 on 04/19/24 | 111.29 on 04/24/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.68 on 04/23/24 |
| 1-Month | |||||
| %Chg | -11.72% since 03/22/24 | -2.79% since 03/25/24 | -8.88% since 03/25/24 | -2.60% since 03/25/24 | -7.10% since 03/25/24 |
| Low | 1.2500 on 04/18/24 | 97.00 on 04/03/24 | 47.61 on 04/25/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 |
| High | 1.5999 on 04/09/24 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | -1.34% since 01/24/24 | +4.37% since 01/25/24 | -4.03% since 01/25/24 | -11.84% since 01/25/24 | -15.95% since 01/25/24 |
| Low | 1.2500 on 04/18/24 | 84.06 on 02/13/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 |
| High | 1.7500 on 02/14/24 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 |
| 6-Month | |||||
| %Chg | -6.17% since 10/24/23 | +39.79% since 10/25/23 | -15.90% since 10/25/23 | +0.50% since 10/25/23 | -13.98% since 10/25/23 |
| Low | 1.1500 on 11/20/23 | 62.55 on 11/02/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 |
| High | 1.7500 on 02/14/24 | 115.97 on 01/08/24 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,331 | 41,676,488 | 99,027,448 | 146,436,016 | 83,519,768 |
| Shares Outstanding, K | 3,228 | 382,880 | 2,026,759 | 536,376 | 1,245,077 |
| Annual Sales | 0 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -9,290,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 |
| Last Quarter Net Income | -3,070,000 | 217,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 |
| 60-Month Beta | 1.45 | 1.62 | 0.39 | 0.58 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.99 on 03/25/24 | 0.55 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.53 | 14.67 | 9.97 |